BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 14656239)

  • 1. Oncogenic osteomalacia: culprit tumour detection whole body magnetic resonance imaging.
    Dissanayake AM; Wilson JL; Holdaway IM; Reid IR
    Intern Med J; 2003 Dec; 33(12):615-6. PubMed ID: 14656239
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia.
    Fukumoto S; Takeuchi Y; Nagano A; Fujita T
    Bone; 1999 Sep; 25(3):375-7. PubMed ID: 10495143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic osteomalacia associated with phosphaturic mesenchymal tumour, mixed connective tissue type of the knee.
    Szumera-Ciećkiewicz A; Ptaszyński K; Pawełas A; Rutkowski P
    Pol J Pathol; 2009; 60(4):193-8. PubMed ID: 20200786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical problem-solving. A question well put.
    Reilly BM; Hart PD; Mascarell S; Chatrath H
    N Engl J Med; 2009 Apr; 360(14):1446-51. PubMed ID: 19339725
    [No Abstract]   [Full Text] [Related]  

  • 5. [Osteomalacia of mesenchymatous tumors. Apropos of a new case].
    Lejeune E; Bouvier M; Meunier P; Vauzelle JL; Deplante JP; David L; Llorca G; André-Fouet E
    Rev Rhum Mal Osteoartic; 1979 Mar; 46(3):187-93. PubMed ID: 472647
    [No Abstract]   [Full Text] [Related]  

  • 6. Case 3. Oncogenic osteomalacia associated with hemangiopericytoma localized by octreotide scan.
    Auethavekiat P; Roberts JR; Biega TJ; Toney MO; Christensen RS; Belnap CM; Berenberg JL
    J Clin Oncol; 2005 May; 23(15):3626-8. PubMed ID: 15908675
    [No Abstract]   [Full Text] [Related]  

  • 7. Oncogenic osteomalacia secondary to a hemangiopericytoma of the hip: case report.
    Baronofsky SI; Kalbhen CL; Demos TC; Sizemore GW
    Can Assoc Radiol J; 1999 Feb; 50(1):26-8. PubMed ID: 10047746
    [No Abstract]   [Full Text] [Related]  

  • 8. Intracranial phosphaturic mesenchymal tumors: report of 2 cases.
    Mathis DA; Stehel EJ; Beshay JE; Mickey BE; Folpe AL; Raisanen J
    J Neurosurg; 2013 Apr; 118(4):903-7. PubMed ID: 23350780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical case seminar: Fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia.
    Nelson AE; Bligh RC; Mirams M; Gill A; Au A; Clarkson A; Jüppner H; Ruff S; Stalley P; Scolyer RA; Robinson BG; Mason RS; Bligh PC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4088-94. PubMed ID: 12970268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of tumor-induced osteomalacia on the bone mineralization process.
    Nawrot-Wawrzyniak K; Varga F; Nader A; Roschger P; Sieghart S; Zwettler E; Roetzer KM; Lang S; Weinkamer R; Klaushofer K; Fratzl-Zelman N
    Calcif Tissue Int; 2009 Apr; 84(4):313-23. PubMed ID: 19219382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging of oncogenic osteomalacia.
    Gershinsky M; Croitoru S; Dickstein G; Bardicef O; Gelman R; Barmeir E
    Isr Med Assoc J; 2007 Jul; 9(7):566-7. PubMed ID: 17710796
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bone lesions in a 59-year-old male].
    Mariñosa M; Valderas G; Tapia G
    Med Clin (Barc); 2003 Mar; 120(9):353-6. PubMed ID: 12646114
    [No Abstract]   [Full Text] [Related]  

  • 13. Oncogenic osteomalacia: lesion detection by MR skeletal survey.
    Avila NA; Skarulis M; Rubino DM; Doppman JL
    AJR Am J Roentgenol; 1996 Aug; 167(2):343-5. PubMed ID: 8686600
    [No Abstract]   [Full Text] [Related]  

  • 14. Phosphaturic mesenchymal tumour-mixed connective tissue variant without oncogenic osteomalacia.
    Winters R; Bihlmeyer S; McCahill L; Cooper K
    J Clin Pathol; 2009 Aug; 62(8):760-1. PubMed ID: 19638551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occult nasal sinus tumours causing oncogenic osteomalacia.
    Kenealy H; Holdaway I; Grey A
    Eur J Intern Med; 2008 Nov; 19(7):516-9. PubMed ID: 19013380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body MR imaging in detecting phosphaturic mesenchymal tumor (PMT) in tumor-induced hypophosphatemic osteomalacia.
    Nakanishi K; Sakai M; Tanaka H; Tsuboi H; Hashimoto J; Hashimoto N; Tomiyama N
    Magn Reson Med Sci; 2013 Mar; 12(1):47-52. PubMed ID: 23474956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic osteomalacia.
    McClure J; Smith PS
    J Clin Pathol; 1987 Apr; 40(4):446-53. PubMed ID: 3584490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Following the forgotten phosphorus.
    Nair LT; Dodd L; Weber TJ
    Am J Med; 2009 Dec; 122(12):1093-5. PubMed ID: 19958885
    [No Abstract]   [Full Text] [Related]  

  • 19. Phosphaturic mesenchymal tumor of the tibia with oncogenic osteomalacia in a teenager.
    Farmakis SG; Siegel MJ
    Pediatr Radiol; 2015 Aug; 45(9):1423-6. PubMed ID: 25721582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octreotide scanning in the detection of a mesenchymal tumour in the pubic symphysis causing hypophosphataemic osteomalacia.
    Moran M; Paul A
    Int Orthop; 2002; 26(1):61-2. PubMed ID: 11954853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.